DLG1 and schizophrenia: Consistent with our previous case‒control study (1138 patients with schizophrenia vs. 1036 healthy controls) [9, 21], no relationship was found between the rs3915512 polymorphism and patient diagnosis, which suggested that the effects of SAP97 in schizophrenia may not confer risk for the disorder.